Cellectis
CLLS
#7755
Rank
โ‚น32.61 B
Marketcap
โ‚น319.29
Share price
0.28%
Change (1 day)
124.82%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚น32.61 Billion

As of February 2026 Cellectis has a market cap of โ‚น32.61 Billion. This makes Cellectis the world's 7755th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น32.61 B-23.77%
2025โ‚น42.77 B246.68%
2024โ‚น12.33 B-32.77%
2023โ‚น18.35 B126.65%
2022โ‚น8.09 B-71.6%
2021โ‚น28.51 B-69.42%
2020โ‚น93.24 B75.32%
2019โ‚น53.18 B3.93%
2018โ‚น51.17 B-20.48%
2017โ‚น64.35 B56.41%
2016โ‚น41.14 B-42.34%
2015โ‚น71.36 B157.11%
2014โ‚น27.75 B570.96%
2013โ‚น4.13 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Cellectis was reported to be:

โ‚น23.01 Billion
by Nasdaq info icon info icon
โ‚น32.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚น7.409 T 22,619.18%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚น149.73 B 359.12%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น121.21 B 271.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น41.39 B 26.93%๐Ÿ‡บ๐Ÿ‡ธ USA